EdgarLookup

RYAN SPECIALTY HOLDINGS, INC. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that RYAN SPECIALTY HOLDINGS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
2.1%
Profit Margin
Net income ÷ revenue
0.6%
Return on Assets
Net income ÷ assets
14.37x
Debt-to-Equity
Total liabilities ÷ equity
+21.3%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.05B Feb 13, 2026
FY2025 Dec 31, 2024 $2.52B Feb 13, 2026
FY2025 Dec 31, 2023 $2.08B Feb 13, 2026
FY2024 Dec 31, 2022 $1.73B Feb 21, 2025
FY2023 Dec 31, 2021 $1.43B Feb 28, 2024
FY2022 Dec 31, 2020 $1.02B Mar 1, 2023
FY2021 Dec 31, 2019 $765.11M Mar 16, 2022

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.99B Feb 13, 2026
FY2025 Dec 31, 2024 $2.46B Feb 13, 2026
FY2025 Dec 31, 2023 $2.03B Feb 13, 2026
FY2024 Dec 31, 2022 $1.71B Feb 21, 2025

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $63.40M Feb 13, 2026
FY2025 Dec 31, 2024 $94.67M Feb 13, 2026
FY2025 Dec 31, 2023 $61.04M Feb 13, 2026
FY2024 Dec 31, 2022 $61.05M Feb 21, 2025
FY2021 Dec 31, 2021 ($7.06M) Mar 16, 2022
FY2022 Dec 31, 2020 $68.10M Mar 1, 2023
FY2021 Dec 31, 2019 $64.17M Mar 16, 2022

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $493.64M Feb 13, 2026
FY2025 Dec 31, 2024 $427.81M Feb 13, 2026
FY2025 Dec 31, 2023 $359.08M Feb 13, 2026
FY2024 Dec 31, 2022 $289.51M Feb 21, 2025
FY2023 Dec 31, 2021 $186.62M Feb 28, 2024
FY2022 Dec 31, 2020 $158.54M Mar 1, 2023
FY2021 Dec 31, 2019 $101.04M Mar 16, 2022

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $643.67M Feb 13, 2026
FY2025 Dec 31, 2024 $514.87M Feb 13, 2026
FY2025 Dec 31, 2023 $477.20M Feb 13, 2026
FY2024 Dec 31, 2022 $335.51M Feb 21, 2025
FY2023 Dec 31, 2021 $273.49M Feb 28, 2024
FY2022 Dec 31, 2020 $135.39M Mar 1, 2023
FY2021 Dec 31, 2019 $149.51M Mar 16, 2022

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $10.56B Feb 13, 2026
FY2025 Dec 31, 2024 $9.65B Feb 13, 2026
FY2024 Dec 31, 2023 $7.25B Feb 21, 2025
FY2023 Dec 31, 2022 $6.38B Feb 28, 2024
FY2022 Dec 31, 2021 $5.46B Mar 1, 2023
FY2021 Dec 31, 2020 $4.53B Mar 16, 2022

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $9.31B Feb 13, 2026
FY2025 Dec 31, 2024 $8.55B Feb 13, 2026
FY2024 Dec 31, 2023 $6.27B Feb 21, 2025
FY2023 Dec 31, 2022 $5.57B Feb 28, 2024
FY2022 Dec 31, 2021 $4.86B Mar 1, 2023
FY2021 Dec 31, 2020 $4.22B Mar 16, 2022

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $648.07M Feb 13, 2026
FY2025 Dec 31, 2024 $627.66M Feb 13, 2026
FY2024 Dec 31, 2023 $559.75M Feb 21, 2025
FY2023 Dec 31, 2022 $478.41M Feb 28, 2024

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.23B Feb 13, 2026
FY2025 Dec 31, 2024 $2.65B Feb 13, 2026
FY2025 Dec 31, 2023 $1.65B Feb 13, 2026
FY2024 Dec 31, 2022 $1.31B Feb 21, 2025
FY2023 Dec 31, 2021 $1.31B Feb 28, 2024
FY2022 Dec 31, 2020 $1.22B Mar 1, 2023
FY2021 Dec 31, 2019 $528.51M Mar 16, 2022

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $120.35M Feb 13, 2026
FY2025 Dec 31, 2024 $122.94M Feb 13, 2026
FY2024 Dec 31, 2023 $114.42M Feb 21, 2025
FY2023 Dec 31, 2022 $53.99M Feb 28, 2024
FY2022 Dec 31, 2021 ($7.06M) Mar 1, 2023

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $158.32M Feb 13, 2026
FY2025 Dec 31, 2024 $540.20M Feb 13, 2026
FY2025 Dec 31, 2023 $838.79M Feb 13, 2026
FY2024 Dec 31, 2022 $992.72M Feb 21, 2025
FY2023 Dec 31, 2021 $1.14B Feb 28, 2024
FY2023 Dec 31, 2020 $895.70M Feb 28, 2024
FY2022 Dec 31, 2019 $402.16M Mar 1, 2023
FY2021 Dec 31, 2018 $338.11M Mar 16, 2022

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.35B Feb 13, 2026
FY2024 Dec 31, 2024 $3.28B Feb 21, 2025
FY2023 Dec 31, 2023 $1.97B Feb 28, 2024
FY2022 Dec 31, 2022 $1.98B Mar 1, 2023
FY2021 Dec 31, 2021 $1.59B Mar 16, 2022
FY2021 Dec 31, 2020 $1.59B Mar 16, 2022

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $62.34M Feb 13, 2026
FY2025 Dec 31, 2024 $80.24M Feb 13, 2026
FY2025 Dec 31, 2023 $0 Feb 13, 2026
FY2024 Dec 31, 2022 $0 Feb 21, 2025